Popular Articles

Rush University Medical Center Hosts Conference Examining Chicago Breastfeeding Rates And Ways To Reduce The Disparities
Over 100 certified breastfeeding peer counselors, lactation consultants, nurses, physicians, dietitians and community health workers are expected to gather at Rush University Medical Center on Thursday, August 6 from 8 a.m. until 1 p.m. in Room 500 at 1725 W. Harrison Street, Chicago, to attend the Griffin Inaugural Conference on Breastfeeding: The Primary Foundation for Health.
diet pills
CytRx's Tamibarotene Receives Positive Opinion From The Committee For Orphan Medicinal Products In The European Union For Treatment Of APL
CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company engaged in the development of high-value human therapeutics, announced that its lead drug candidate tamibarotene has received official notification from the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency (EMEA) that a positive opinion was made regarding the application for orphan medicinal product for the treatment of acute promyelocytic leukemia (APL). The positive opinion of the COMP has now been forwarded to the EU commission for final approval and publication in the community register. This favorable opinion for tamibarotene in the European Union (EU) is in addition to the Orphan Drug Designation for APL and Fast Track Designation for the treatment of adult patients with relapsed or refractory APL following treatment with all-trans retinoic acid (ATRA) and arsenic trioxide granted by the U.S. Food and Drug Administration (FDA) in October 2007.
News of the day
Soaring Summer Temperatures Spell Danger: What To Do To Protect Yourself
From the west to east coast, Americans are experiencing record-breaking temperatures. Some states are reporting triple-digit numbers and the heat has been the cause of several reported deaths. "Children and the elderly are considered the most vulnerable population. It is harder for their bodies to respond to these high temperatures," said Richard N. Bradley, M.D., associate professor of emergency medicine and chief of EMS and disaster medicine at The University of Texas Medical School at Houston.
Cardiovascular

Patient Radiation Exposure During Interventional Procedures Is A Concern For Some Developing Countries

Interventional radiology procedures are on the rise in developing countries and there is a significant need for optimization of these procedures to ensure patient safety. Many facilities in these countries lack the concept of patient dose estimation and dose management, putting patients at a higher risk of developing complications due to overexposure from radiation during interventional procedures, according to a study performed by the International Atomic Energy Agency in Vienna, Austria. The study included data from 55 hospitals in 20 countries - mostly in Eastern Europe, five in Africa and six in Asia. "We found that a substantial number of coronary angioplasty procedures performed in the developing countries in this study are above the currently known dose reference level," said Madan M. Rehani, PhD, coordinator of the study. "We also found that kerma area product (KAP), a method to determine dose estimations, was available in almost half of the facilities, but none had experience in its use," said Dr. Rehani. "There is a significant lack of awareness about patient dose estimations and dose management among interventional radiologists and cardiologists in developing countries. Our goal is to introduce these concepts to them and achieve effective implementation," he said. "Most training centers need to establish a culture of dose assessment and dose management - including programs for residents with radiation protection as an essential component - to improve patient safety. Dose monitoring devices for angiography equipment should also be considered," said Dr. Rehani. This study appears in the August issue of the American Journal of Roentgenology. Abstract Heather Curry American Roentgen Ray Society


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):